Devyser Diagnostics AB (ST:DVYSR) — Stock Price

Skr63.60 SEK
▼ -2.90% today

Devyser Diagnostics AB (ST:DVYSR) is currently trading at Skr63.60 SEK, down 2.90% today. Over the past 52 weeks, shares have ranged between Skr58.20 and Skr157.80. This page tracks Devyser Diagnostics AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Devyser Diagnostics AB.

Devyser Diagnostics AB (DVYSR) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Devyser Diagnostics AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Devyser Diagnostics AB Income Statement — Revenue, Profit & Earnings by Year

Devyser Diagnostics AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr250.50 Million Skr216.90 Million Skr169.30 Million Skr126.61 Million Skr93.48 Million
Cost of Revenue Skr48.60 Million Skr44.20 Million Skr21.20 Million Skr20.84 Million Skr18.82 Million
Gross Profit Skr201.90 Million Skr172.70 Million Skr148.10 Million Skr105.77 Million Skr74.66 Million
Research & Development Skr18.00 Million Skr43.10 Million Skr41.10 Million Skr28.64 Million Skr20.82 Million
SG&A Skr173.30 Million Skr51.30 Million Skr42.00 Million Skr37.90 Million Skr28.78 Million
Total Operating Expenses Skr191.30 Million Skr231.00 Million Skr204.60 Million Skr160.72 Million Skr96.47 Million
Operating Income Skr10.60 Million Skr-58.30 Million Skr-56.50 Million Skr-54.95 Million Skr-21.81 Million
EBITDA Skr37.70 Million Skr-31.20 Million Skr-43.80 Million Skr-46.02 Million Skr-18.05 Million
EBIT Skr10.60 Million Skr-54.10 Million Skr-56.90 Million Skr-52.18 Million Skr-21.33 Million
Interest Expense Skr13.60 Million Skr3.50 Million Skr800.00K Skr500.00K Skr939.00K
Income Before Tax Skr-2.60 Million Skr-57.60 Million Skr-54.40 Million Skr-52.72 Million Skr-22.28 Million
Income Tax Expense Skr5.80 Million Skr3.90 Million Skr-800.00K Skr-6.80 Million Skr-1.18 Million
Net Income Skr-8.40 Million Skr-61.50 Million Skr-53.60 Million Skr-45.95 Million Skr-20.73 Million

Devyser Diagnostics AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Devyser Diagnostics AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr469.70 Million Skr473.80 Million Skr510.10 Million Skr500.63 Million Skr456.87 Million
Total Current Assets Skr204.30 Million Skr252.30 Million Skr341.80 Million Skr412.11 Million Skr412.66 Million
Cash & Equivalents — — — — —
Short-term Investments — — Skr-1.00 — —
Net Receivables Skr67.00 Million Skr74.60 Million Skr45.30 Million Skr33.38 Million Skr26.16 Million
Inventory Skr37.00 Million Skr30.20 Million Skr20.60 Million Skr10.28 Million Skr6.95 Million
Property, Plant & Equipment — — — — —
Goodwill Skr6.60 Million Skr7.00 Million Skr6.70 Million Skr6.77 Million Skr236.00K
Total Liabilities Skr115.40 Million Skr124.80 Million Skr125.00 Million Skr69.19 Million Skr40.18 Million
Total Current Liabilities Skr70.90 Million Skr72.60 Million Skr62.90 Million Skr51.23 Million Skr29.43 Million
Long-term Debt Skr300.00K Skr300.00K Skr600.00K Skr600.00K Skr0.00
Net Debt Skr11.90 Million Skr-85.40 Million Skr-188.10 Million Skr-342.40 Million Skr-364.68 Million
Total Stockholder Equity Skr354.30 Million Skr349.10 Million Skr385.10 Million Skr431.44 Million Skr416.68 Million
Retained Earnings Skr-194.90 Million Skr-189.00 Million Skr-130.20 Million Skr-77.94 Million Skr-33.03 Million

Devyser Diagnostics AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Devyser Diagnostics AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr8.20 Million Skr-46.80 Million Skr-69.70 Million Skr-40.50 Million Skr-16.48 Million
Capital Expenditures Skr1.50 Million Skr76.90 Million Skr32.00 Million Skr25.80 Million Skr8.80 Million
Free Cash Flow Skr6.70 Million Skr-123.70 Million Skr-101.70 Million Skr-66.30 Million Skr-25.28 Million
Investing Cash Flow Skr-70.70 Million Skr-76.90 Million Skr-32.00 Million Skr-23.86 Million Skr-10.32 Million
Financing Cash Flow Skr-2.80 Million Skr7.80 Million Skr-200.00K Skr48.94 Million Skr395.93 Million
Dividends Paid — — — — —
Stock-Based Compensation — — — — —
Depreciation Skr27.10 Million Skr27.70 Million Skr9.80 Million Skr6.16 Million Skr3.28 Million
Change in Cash Skr-67.00 Million Skr-118.40 Million Skr-100.70 Million Skr-14.04 Million Skr369.30 Million

Devyser Diagnostics AB Earnings History — EPS Actual vs. Analyst Estimates

Track Devyser Diagnostics AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 20, 2026 — 0.47 —
Apr 27, 2026 0.12 0.10 +12.88%
Feb 11, 2026 0.58 0.29 +100.00%
Nov 04, 2025 -0.12 0.11 -209.09%
Jul 22, 2025 0.05 -0.09 +155.56%
Apr 29, 2025 -0.85 -0.38 -123.68%
Feb 13, 2025 -0.19 -0.57 +66.67%
Oct 30, 2024 -0.91 -0.83 -9.64%